Literature DB >> 15309487

[Accumulation of lipid particles in Bruch's membrane of LDL receptor knockout mice as a model of age-related macular degeneration].

M Rudolf1, B Ivandic, J Winkler, U Schmidt-Erfurth.   

Abstract

BACKGROUND: Atherosclerosis is a suspected risk factor for the development of neovascular age-related macular degeneration (AMD).
METHODS: We used a well-established murine knockout model with low-density lipoprotein (LDL) receptor deficiency for atherosclerotic vascular pathogenesis to evaluate changes in Bruch's membrane due to high cholesterol levels. Blood cholesterol levels were modified by the diet fed (standard rodent diet or high-fat diet western type). Animals were sacrificed and plasma cholesterol levels were determined. Eyes were examined by transmission electron microscopy (TEM).
RESULTS: Plasma total cholesterol levels were highest in LDL receptor-deficient mice after high-fat diet and elevated in LDL receptor-deficient mice after standard diet compared to control mice with and without special high-fat diet. While Bruch's membranes of control animals did not exhibit any visible changes by TEM even after a high-fat diet, membrane-bound translucent particles were seen in all membranes in knockout mice. The amount of these particles was substantially increased and membranes were thickened in knockout animals following high-fat diet with additional deposits of non-membrane-bound particles.
CONCLUSION: LDL receptor-deficient mice exhibited a degeneration of Bruch's membrane with accumulation of lipid particles, which is further increased after fat intake due to elevated blood lipid levels. In our opinion, this animal model is suitable for investigating more aspects in the pathogenesis of neovascular AMD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309487     DOI: 10.1007/s00347-003-0942-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  35 in total

1.  Pathologic changes in the retinal pigment epithelium and Bruch's membrane of fat-fed atherogenic mice.

Authors:  M V Miceli; D A Newsome; D J Tate; T G Sarphie
Journal:  Curr Eye Res       Date:  2000-01       Impact factor: 2.424

Review 2.  Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

Authors:  P Mitchell; W Smith; K Attebo; J J Wang
Journal:  Ophthalmology       Date:  1995-10       Impact factor: 12.079

3.  Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group.

Authors:  L Hyman; A P Schachat; Q He; M C Leske
Journal:  Arch Ophthalmol       Date:  2000-03

4.  Dietary fat and fish intake and age-related maculopathy.

Authors:  W Smith; P Mitchell; S R Leeder
Journal:  Arch Ophthalmol       Date:  2000-03

5.  Correlation of blood-glucose control with oxidative metabolites in plasma and vitreous body of diabetic patients.

Authors:  A J Augustin; H B Dick; F Koch; U Schmidt-Erfurth
Journal:  Eur J Ophthalmol       Date:  2002 Mar-Apr       Impact factor: 2.597

6.  VEGF localisation in diabetic retinopathy.

Authors:  M Boulton; D Foreman; G Williams; D McLeod
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

7.  A prospective study of cigarette smoking and age-related macular degeneration in women.

Authors:  J M Seddon; W C Willett; F E Speizer; S E Hankinson
Journal:  JAMA       Date:  1996-10-09       Impact factor: 56.272

8.  Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1992-12

9.  [Biochemical and histochemical analysis of age related lipid deposits in Bruch's membrane].

Authors:  D Pauleikhoff; G Sheraidah; J Marshall; A C Bird; A Wessing
Journal:  Ophthalmologe       Date:  1994-12       Impact factor: 1.059

10.  Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model.

Authors:  T Tobe; S Ortega; J D Luna; H Ozaki; N Okamoto; N L Derevjanik; S A Vinores; C Basilico; P A Campochiaro
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

View more
  7 in total

Review 1.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

2.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

3.  A human apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD.

Authors:  Masashi Fujihara; Emil Bartels; Lars B Nielsen; James T Handa
Journal:  Exp Eye Res       Date:  2009-02-07       Impact factor: 3.467

4.  Increased expression of vascular endothelial growth factor associated with accumulation of lipids in Bruch's membrane of LDL receptor knockout mice.

Authors:  M Rudolf; B Winkler; Z Aherrahou; L C Doehring; P Kaczmarek; U Schmidt-Erfurth
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

Review 5.  Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).

Authors:  Hema L Ramkumar; Jun Zhang; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2010-03-03       Impact factor: 21.198

6.  CD36 plays an important role in the clearance of oxLDL and associated age-dependent sub-retinal deposits.

Authors:  Emilie Picard; Marianne Houssier; Kim Bujold; Przemyslaw Sapieha; William Lubell; Allison Dorfman; Julie Racine; Pierre Hardy; Maria Febbraio; Pierre Lachapelle; Huy Ong; Florian Sennlaub; Sylvain Chemtob
Journal:  Aging (Albany NY)       Date:  2010-12       Impact factor: 5.682

Review 7.  Central Role of Oxidative Stress in Age-Related Macular Degeneration: Evidence from a Review of the Molecular Mechanisms and Animal Models.

Authors:  Samuel Abokyi; Chi-Ho To; Tim T Lam; Dennis Y Tse
Journal:  Oxid Med Cell Longev       Date:  2020-02-10       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.